Calreticulin promotes cell motility and enhances resistance to anoikis through STAT3-CTTN-Akt pathway in esophageal squamous cell carcinoma

Oncogene

Volumn 28, Issue 42, 2009, Pages 3714-3722

  Du, X L ^a   Yang, H ^a   Liu, S G ^a   Luo, M L ^a   Hao, J J ^a   Zhang, Y ^a   Lin, D C ^a   Xu, X ^a   Cai, Y ^a   Zhan, Q M ^a   Wang, M R ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

Anoikis; Calreticulin; Cortactin; Motility; STAT3

Indexed keywords

CALRETICULIN; CORTACTIN; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SMALL INTERFERING RNA; STAT3 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANOIKIS; ARTICLE; CARCINOGENESIS; CELL FUNCTION; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RNA INTERFERENCE; TRANSCRIPTION REGULATION;

AGAR; ANIMALS; ANOIKIS; CALRETICULIN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; CORTACTIN; DOWN-REGULATION; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, NUDE; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-AKT; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC;

EID: 70350566519     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2009.237     Document Type: Article

References (37)

1. Alaiya A, Roblick U, Egevad L, Carlsson A, Franzen B, Volz D et al. (2000). Polypeptide expression in prostate hyperplasia and prostate adenocarcinoma. Anal Cell Pathol 21: 1-9.
2. Bini L, Magi B, Marzocchi B, Arcuri F, Tripodi S, Cintorino M et al. (1997). Protein expression profiles in human breast ductal carcinoma and histologically normal tissue. Electrophoresis 18: 2832-2841.
3. Bourguignon LY, Zhu H, Shao L, Chen YW. (2001). CD44 interaction with c-Src kinase promotes cortactin-mediated cytoskeleton function and hyaluronic acid-dependent ovarian tumor cell migration. J Biol Chem 276: 7327-7336.
4. Bowden ET, Barth M, Thomas D, Glazer RI, Mueller SC. (1999). An invasion-related complex of cortactin, paxillin and PKCmu associates with invadopodia at sites of extracellular matrix degradation. Oncogene 18: 4440-4449.
5. Chahed K, Kabbage M, Ehret-Sabatier L, Lemaitre-Guillier C, Remadi S, Hoebeke J et al. (2005). Expression of fibrinogen E-fragment and fibrin E-fragment is inhibited in the human infiltrating ductal carcinoma of the breast: the two-dimensional electrophoresis and MALDI-TOF-mass spectrometry analyses. Int J Oncol 27: 1425-1431.
6. Chen D, Texada DE, Duggan C, Liang C, Reden TB, Kooragayala LM et al. (2005). Surface calreticulin mediates muramyl dipeptide-induced apoptosis in RK13 cells. J Biol Chem 280: 22425-122236
7. Chuma M, Sakamoto M, Yasuda J, Fujii G, Nakanishi K, Tsuchiya A et al. (2004). Overexpression of cortactin is involved in motility and metastasis of hepatocellular carcinoma. J Hepatol 41: 629-636.
8. Clark ES, Brown B, Whigham AS, Kochaishvili A, Yarbrough WG, Weaver AM. (2009). Aggressiveness of HNSCC tumors depends on expression levels of cortactin, a gene in the 11q13 amplicon. Oncogene 28: 431-444.
9. Coppolino MG, Woodside MJ, Demaurex N, Grinstein S, St-Arnaud R, Dedhar S. (1997). Calreticulin is essential for integrin-mediated calcium signalling and cell adhesion. Nature 386: 843-847.
10. Du XL, Hu H, Lin DC, Xia SH, Shen XM, Zhang Y et al. (2007). Proteomic profiling of proteins dysregulted in Chinese esophageal squamous cell carcinoma. J Mol Med 85: 863-875.
11. Eric A, Juranic Z, Milovanovic Z, Markovic I, Inic M, Stanojevic-Bakic N et al. (2009). Effects of humoral immunity and calreticulin overexpression on postoperative course in breast cancer. Pathol Oncol Res 1: 89-90.
12. Gold LI, Rahman M, Blechman KM, Greives MR, Churgin S, Michaels J et al. (2006). Overview of the role for calreticulin in the enhancement of wound healing through multiple biological effects. J Investig Dermatol Symp Proc 11: 57-65.
13. Hayashida Y, Urata Y, Muroi E, Kono T, Miyata Y, Nomata K et al. (2006). Calreticulin represses E-cadherin gene expression in Madin-Darby canine kidney cells via Slug. J Biol Chem 281: 32469-33284.
14. Helbling D, Mueller BU, Timchenko NA, Hagemeijer A, Jotterand M, Meyer-Monard S et al. (2004). The leukemic fusion gene AML1-MDS1-EVI1 suppresses CEBPA in acute myeloid leukemia by activation of Calreticulin. Proc Natl Acad Sci USA 101: 13312-13317.
15. Huang YH, Chang AY, Huang CM, Huang SW, Chan SH. (2002). Proteomic analysis of lipopolysaccharide-induced apoptosis in PC12 cells. Proteomics 2: 1220-1228.
16. Kageyama K, Ihara Y, Goto S, Urata Y, Toda G, Yano K et al. (2002). Overexpression of calreticulin modulates protein kinase B/Akt signaling to promote apoptosis during cardiac differentiation of cardiomyoblast H9c2 cells. J Biol Chem 277: 19255-19264.
17. Kim YM, Kim HJ, Song EJ, Lee KJ. (2004). Glucuronic acid is a novel inducer of heat shock response. Mol Cell Biochem 259: 23-33.
18. Kinley AW, Weed SA, Weaver AM, Karginov AV, Bissonette E, Cooper JA et al. (2003). Cortactin interacts with WIP in regulating Arp2/3 activation and membrane protrusion. Curr Biol 13: 384-393.
19. Li Y, Tondravi M, Liu J, Smith E, Haudenschild CC, Kaczmarek M et al. (2001). Cortactin potentiates bone metastasis of breast cancer cells. Cancer Res 61: 6906-6911.
20. Lim S, Chang W, Lee BK, Song H, Hong JH, Lee S et al. (2008). Enhanced calreticulin expression promotes calcium-dependent apoptosis in postnatal cardiomyocytes. Mol Cells 25: 390-396.
21. Lua BL, Low BC. (2005). Cortactin phosphorylation as a switch for actin cytoskeletal network and cell dynamics control. FEBS Lett 579: 577-585.
22. Luo ML, Shen XM, Zhang Y, Wei F, Xu X, Cai Y et al. (2006). Amplification and overexpression of CTTN (EMS1) contribute to the metastasis of esophageal squamous cell carcinoma by promoting cell migration and anoikis resistance. Cancer Res 66: 11690-11699.
23. Mesaeli N, Phillipson C. (2004). Impaired p53 expression, function, and nuclear localization in calreticulin-deficient cells. Mol Biol Cell 15: 1862-1870.
24. Michalak M, Burns K, Andrin C, Mesaeli N, Jass GH, Busaan JL et al. (1996). Endoplasmic reticulum form of calreticulin modulates glucocorticoid-sensitive gene expression. J Biol Chem 271: 29436-29445.
25. Michalak M, Corbett EF, Mesaeli N, Nakamura K, Opas M. (1999). Calreticulin: one protein, one gene, many functions. Biochem J 344(Part 2): 281-292.
26. Nishimori T, Tomonaga T, Matsushita K, Oh-Ishi M, Kodera Y, Maeda T et al. (2006). Proteomic analysis of primary esophageal squamous cell carcinoma reveals downregulation of a cell adhesion protein, periplakin. Proteomics 6: 1011-1018.
27. Okunaga T, Urata Y, Goto S, Matsuo T, Mizota S, Tsutsumi K et al. (2006). Calreticulin, a molecular chaperone in the endoplasmic reticulum, modulates radiosensitivity of human glioblastoma U251MG cells. Cancer Res 66: 8662-86671.
28. Pallero MA, Elzie CA, Chen J, Mosher DF, Murphy-Ullrich JE. (2008). Thrombospondin 1 binding to calreticulin-LRP1 signals resistance to anoikis. FASEB J 22: 3968-3979.
29. Rauch F, Prud'homme J, Arabian A, Dedhar S, St-Arnaud R. (2000). Heart, brain, and body wall defects in mice lacking calreticulin. Exp Cell Res 256: 105-111.
30. Rothschild BL, Shim AH, Ammer AG, Kelley LC, Irby KB, Head JA et al. (2006). Cortactin overexpression regulates actin-related protein 2/3 complex activity, motility, and invasion in carcinomas with chromosome 11q13 amplification. Cancer Res 66: 8017-8025.
31. Shago M, Flock G, Leung Hagesteijn CY, Woodside M, Grinstein S, Giguere V et al. (1997). Modulation of the retinoic acid and retinoid X receptor signaling pathways in P19 embryonal carcinoma cells by calreticulin. Exp Cell Res 230: 50-60.
32. Tatu U, Helenius A. (1997). Interactions between newly synthesized glycoproteins, calnexin and a network of resident chaperones in the endoplasmic reticulum. J Cell Biol 136: 555-565.
33. Valentijn AJ, Zouq N, Gilmore AP. (2004). Anoikis. Biochem Soc Trans 32: 421-425.
34. Vanoverberghe K, Vanden Abeele F, Mariot P, Lepage G, Roudbar-aki M, Bonnal JL et al. (2004). Ca2+ homeostasis and apoptotic resistance of neuroendocrine-differentiated prostate cancer cells. Cell Death Differ 11: 321-330.
35. Vougas K, Gaitanarou E, Marinos E, Kittas C, Voloudakis-Baltatzis IE. (2008). Two-dimensional electrophoresis and immunohisto-chemical study of calreticulin in colorectal adenocarcinoma and mirror biopsies. J BUON 13: 101-107.
36. Weaver AM. (2008). Cortactin in tumor invasiveness. Cancer Lett 265: 157-166.
37. Zhang Y, Zhang M, Dong H, Yong S, Li X, Olashaw N et al. (2009). Deacetylation of cortactin by SIRT1 promotes cell migration. Oncogene 28: 445-460.